1 / 32

Exon-level transcriptome analysis of HIV-1 infected and bystander primary CD4+ T lymphocytes

Exon-level transcriptome analysis of HIV-1 infected and bystander primary CD4+ T lymphocytes. Michael Imbeault Laboratory of Dr. Michel J. Tremblay Universit é Laval, Québec Canada AIDS 2010 Vienna. Goal.

kovit
Download Presentation

Exon-level transcriptome analysis of HIV-1 infected and bystander primary CD4+ T lymphocytes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Exon-level transcriptome analysis of HIV-1 infected and bystander primary CD4+ T lymphocytes Michael Imbeault Laboratory of Dr. Michel J. Tremblay Université Laval, Québec Canada AIDS 2010 Vienna

  2. Goal • Describe the transcriptomic profile of primary CD4+ T cellsexposed to HIV-1 in vitro • Compare infectedcells and bystandercells

  3. Infection of primary lymphocytes in vitro

  4. Infected (10%) Problem Mock Control • Quantification of RNA - 10 copies vs 12 copies = 1.2 fold • But in infectedcells, its a 3 fold induction

  5. NL4-3-IRES-HSA • Express all viral genes • Allow for separation of infectedcellsusingmagneticbeads • More sensitive than the parental GFP virus (Levy & al) • Detailspublished in Virology. 2009 Oct 10;393(1):160-7

  6. NL4-3-IRES-HSA

  7. NL4-3-IRES-HSA

  8. Human Exon 1.0 ST array • Latest offering from Affymetrix • 1.4 millions probesets • 1 million exons • Covers • All knownhumangenes • in silicopredictedgenes • ESTs • Allow for quantification of expression and determination of alternative splicingevents

  9. Human Exon 1.0 ST array

  10. Protocol

  11. Separation of infectedcells • Isolate a mean of 500 000 infectedcellsstartingfrom • 50 million cellsatday 1 • 25 million cellsatday 2 and 3 • Extraction of RNA using a dual Trizol – Qiagen custom protocol • Quantification of purity by Taqman qRT-PCR against Tat-spliced

  12. Tat-spliced PCR

  13. Analysis • Strict statististicalanalysisusingBioconductor’s LIMMA • FDR 1% • 1.7 fold minimum

  14. Results

  15. Results

  16. Automatedlitteratureanalysis • Automatedanalysis of literatureusingGenomatixBibliosphere • Citation of 2 genes in the same sentence in at least 3 different abstracts • Exported to graph management software Gephi • Gephi.org

  17. Automatedanalysis of literature

  18. Main features • AP-1 (FOS and JUN, someotherrelatedgenes) • A group of genesrelated to activated / effector T cells • Many cytokines associated to Th1, Th2, Th17 • Th17 relatedgenes have higher surexpression values, perhapsindicating a highersusceptibility • p53 relatedgenes

  19. FOS JUN AP-1

  20. Promoter analysis

  21. Cytokine related • Th1 (IFNG, TNF-a, TNF-b, IL1A, IL3) • Th2 (IL4, IL5, IL-10, IL13) • Th17 (IL17A, IL17F, IL21, IL22, IL23R, IRF4)

  22. IL17A IL17F Th17 related genes

  23. IL22 IL23R Th17 related genes

  24. p53 relatedgenes

  25. Automatedanalysis of literature

  26. Alternative splicinganalysis • Used the combination of two of the best algorithms • MADS and PECA-SI • P < 0.01 • Splicing index of at least 0.6 • Exon canbedetected in at least 1/3 of arrays • Filter out exons not currentlyassociatedwithgenes

  27. Alternative splicing results • 547 probes in 372 transcripts • 52% of these are in non-codingUTRs • 48% in coding exons

  28. PTPRC

  29. Alternative splicing - PTPRC

  30. Conclusion • Infectedcells have a transcriptomic profile of highlyactivated / effector / memory T cells • No effectat all in bystandercells • Confirmed a lot of things • Role of p53 in HIV-1 pathogenenis • Manyinteresting candidates • Potentialsusceptibility and restriction factors

  31. Acknowledgements • Michel J. Tremblay • Project Leaders • Corinne Barat, Ph.D. • RéjeanCantin, Ph.D. • Robert Lodge, Ph.D. • Michel Ouellet, Ph.D. • Postdoctoral Fellows • RavendraGarg, Ph.D. • Pranav Kumar, Ph.D. • Guadalupe Andreani, Ph.D. • Masayuki Fujino, Ph.D. • Sandra Côté, Ph.D. • Ph.D. Students • RémiFromentin, M.Sc. • Alexandra Lambert, M.Sc. • Lise-AndréeGobeil, M.Sc. • Jonathan Bertin, M.Sc. • Pascal Jalaguier, M.Sc. • AnissaCheikh, M.Sc. • Alejandro Martin Gomez Lic. • M.Sc. Students • Alexis Danylo, B.Sc. • KatiaGiguère, B.Sc. • Audrey Plante, B.Sc. • Jean-François Bolduc, B.Sc. • VéroniqueVeillette, B.Sc.

  32. Questions

More Related